logo
  Join        Login             Stock Quote

Insiders Bought Mead Johnson Nutrition Company (MJN), Should You?

 November 06, 2012 09:48 AM


(By Rich Bieglmeier) Super-storm Sandy closed the market last Monday and Tuesday. As a result, the number of insider transactions last week was limited; however, some purchases of note were on the shortened week's ledger. Investors who use insider buying to create a list of potential ideas could consider names such as Air Products & Chemicals Inc. (APD), Callaway Golf Co. (ELY), Gevo, Inc. (GEVO), Exact Sciences Corporation (EXAS), and Streamline Health Solutions, Inc. (STRM). All of them caught iStock's attention with multiple purchases or dollar amount.

[Related -Mead Johnson Q4 Profit, Sales Top Estimate, Shares Up]

For this column, Mead Johnson Nutrition Company (MJN) will be our focus. Last week, CFO, Peter Leemputte purchased 3,000 shares at $63.61 for a total investment of $190,819. Director James Cornelius wrote a check for $617,515 to buy 10,000 shares at $61.75.

[Related -Mead Johnson (NYSE:MJN): 'Fear Of The Dragon' - Downgrading To Sector Perform - RBC]

In the past two years, Cornelius made four other purchases. In March or 2011, he bought 10,000 shares at $59.91, another 10,000 at $66.43 in May 2011, 10,000 more in August 2011 at $66.71, and 10,000 more in May 2012 at $81.02. Of the four buys, the director exhibited good timing as the stock climbed to more than $75 following his 2011 buys.

The CFO, on the other hand, has done nothing but exercise options and sell MJN stock in the past 24 months. The number cruncher's buy is more potent in our opinion. After all, who knows a company's finances better than the chief financial officer?

The pair of buys comes on the heels of the stock sinking following from $69.51 to $63.53 following earnings on October 25, 2012. Mead Johnson told the conference call attendees that problems in China while getting better, will lead to a sluggish fourth quarter. Apparently, Leemputte and Cornelius believe the street's reaction was overblown.

iStock thinks investors might be wise to wait before joining forces with the director and CFO. The recent snapback gobbled up 50% of the post-eps selloff. The move is a typical retracement following a big drop. It's been our experience that a test of the low will come before a full recovery takes place.

Overall, we feel Mead Johnson Nutrition Company (MJN) will likely have to work through its China issue during the fourth quarter for Wall Street to become believers again. Fundamentally, iStock feels MJN could still be overvalued with a forward P/E of $19.44 while analysts call for 11.2% eps growth in 2013. And that's if bloated 3rd quarter inventory doesn't put additional pressure on margins and shrink profits.

With that in mind, shareholders might think about writing covered calls now, or a bullish spread if shares flirt with $62.  Traders buy and sell call options with the same expiration month to execute a bullish option spread. For example, buying the January 2013 60 call and selling the January 13 65 call. In our view, the spread trade would be a safer way to follow MJN insider's lead.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageXerox Corp. (XRX): An Insider’s $500,000 Insider Buy

Last week was a healthy week of insider buying as 194 companies reported purchase records. The number read on...

article imageQihoo 360 Technology Co Ltd. (QIHU) Q2 Earnings Preview: A Green Monday

Qihoo 360 Technology Co Ltd. (NYSE:QIHU) will report its second quarter 2014 financial results on Monday, read on...

article imageSix Stocks that Could Outperform in the next 90 days

Earlier today, Goldman Sachs put out its list of the 50 stocks that Matter Most. It’s a list of the 50 read on...

article imageFoot Locker, Inc. (FL) Q2 Earnings Preview: Running Past the Street View

Foot Locker, Inc. (NYSE:FL) plans to report financial results for its second quarter ended August 2, 2014 read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.